I am a health economist with expertise in causal inference, health technology assessment (HTA), economic evaluation, and modelling. I earned my PhD in Economics from the University of Strathclyde, where my research applied regression discontinuity designs to evaluate public policy impacts on women and children’s welfare and health in the Middle East and North Africa.

I held postdoctoral and industry roles at Johnson & Johnson and Pfizer, contributing to vaccine and oncology value strategies. I am currently working as a Postdoctoral Researcher in HTA at Maastricht University, focusing on comparative effectiveness research, stakeholder-driven modelling, and policy-relevant economic evaluations.